While Ascendis Pharma A/S ADR has underperformed by -1.14%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ASND rose by 17.34%, with highs and lows ranging from $183.00 to $111.09, whereas the simple moving average jumped by 15.85% in the last 200 days.
On May 05, 2025, Morgan Stanley Upgraded Ascendis Pharma A/S ADR (NASDAQ: ASND) to Overweight. A report published by RBC Capital Mkts on April 16, 2025, Initiated its previous ‘Outperform’ rating for ASND. UBS also rated ASND shares as ‘Buy’, setting a target price of $196 on the company’s shares in an initiating report dated January 07, 2025. TD Cowen June 25, 2024d its ‘Hold’ rating to ‘Buy’ for ASND, as published in its report on June 25, 2024. Stifel’s report from May 31, 2024 suggests a price prediction of $200 for ASND shares, giving the stock a ‘Buy’ rating. Jefferies also rated the stock as ‘Buy’.
Analysis of Ascendis Pharma A/S ADR (ASND)
Further, the quarter-over-quarter increase in sales is 2.09%, showing a positive trend in the upcoming months.
One of the most important indicators of Ascendis Pharma A/S ADR’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. Taking into account the quick ratio of the company, currently set at 0.71, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and ASND is recording 545.36K average volume. On a monthly basis, the volatility of the stock is set at 6.39%, whereas on a weekly basis, it is put at 5.48%, with a loss of -5.54% over the past seven days. Furthermore, long-term investors anticipate a median target price of $221.90, showing growth from the present price of $160.99, which can serve as yet another indication of whether ASND is worth investing in or should be passed over.
How Do You Analyze Ascendis Pharma A/S ADR Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.78%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 105.51% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
ASND shares are owned by institutional investors to the tune of 105.51% at present.
